AKT1 and major depressive disorder: Recent studies have shown that a single dose of Schisantherin B (15 mg/kg/d) can increase GLT-1 levels and alleviate symptoms of FST-induced depression in FST-induced depressed mice by promoting PI3K/AKT/mTOR pathways.